Skip to main content
logo
Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
35.04
+0.79 (2.31%)
At close: Jul 30, 2026, 4:00 PM EDT
35.03
-0.01 (-0.03%)
After-hours: Jul 30, 2026, 7:43 PM EDT

Pulse Biosciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.750.35--0.71.42
Revenue Growth
-----50.63%-
Gross Profit
0.75-0.19---11.24-0.55
Operating Income
-78.05-76.94-56.26-43.57-58.06-63.01
Net Income
-74.57-72.78-53.59-42.21-58.51-63.66
Earnings Per Share
-1.10-1.08-0.92-0.85-1.72-2.28
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
68.3280.74118.0444.3761.1428.61
Total Debt
7.167.538.99.1410.9611.25
Net Cash (Debt)
61.1673.21109.1435.2250.1817.36
Net Cash Growth
-44.75%-32.93%209.87%-29.81%189.00%90.42%
Net Cash Per Share
0.901.091.870.711.480.62

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-55.2-54.12-36.34-33.04-47.01-54.1
Capital Expenditures
-0.3-0.32-0.13-0.12-0.4-0.44
Free Cash Flow
-55.5-54.44-36.47-33.16-47.41-54.53
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%-54.00%---1606.29%-38.79%
Operating Margin
-10392.10%-21982.60%---8293.86%-4443.86%
Pretax Margin
-2552.33%-19591.71%---8357.86%-4489.42%
Profit Margin
-2552.33%-19591.70%---8357.86%-4489.42%
FCF Margin
-7390.01%-15553.40%---6773.43%-3845.84%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
3229.172661.25--147.34310.36